Category Archives for "News"

Abattis and Management Overcome Legal and Regulatory Allegations

After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication Vancouver, British Columbia /March19, 2021/ Abattis Bioceuticals Corp. (“Abattis” or the “Company”)(OTC:ATTBF) is pleased to announce significant progress regarding its dealings with the British Columbia Securities Commission, theClass Action Lawsuit and its Operations. The Securities Commission On November 26, 2018, […]

Read More

Abattis Provides Comprehensive Update

June 20, 2020    |    Abattis Bioceuticals
VANCOUVER, BRITISH COLUMBIA / June 17, 2020 / Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide a comprehensive corporate and operational update.

Read More

Abattis Provides Update on Trading Halt and Corporate Developments

Nov 8, 2019    |    Abattis Bioceuticals
VANCOUVER, BRITISH COLUMBIA / Nov 8th, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) November 8, 2019 / Abattis Bioceuticals Corp. (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments related to Abattis since the trading of the Company’s common shares on the Canadian Stock Exchange (the “CSE”) was halted on February 4, 2019 (the “Halt”).

Read More

Abattis Announces Successful Closing of Pro Natura Acquisition

May 21, 2019    |    Abattis Bioceuticals
VANCOUVER, BRITISH COLUMBIA / May 21st, 2019 / Abattis Bioceuticals Corp (the “Company” or “Abattis“) (CSE:ATT) (OTC:ATTBF) is pleased to announce that, further to its news release dated April 2nd, 2019, the Company’s wholly-owned subsidiary, 1185277 B.C. Ltd. (the “Acquisition Subsidiary”) has successfully closed the acquisition (the “Acquisition”) of Pro Natura BV (“Pro Natura”).

Read More
1 2 3 12